Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
New Survey Suggests Psilocybin Eases Psychological Distress From Childhood Trauma
October 19, 2023
Tags
News
Childhood trauma
Psychedelic/Assisted Therapies
From
Benzinga
EXCLUSIVE: Reason For Hope On Veteran Group Efforts, Comments To FDA & 2023 Expectations
October 18, 2023
Tags
Benzinga
News
FDA
From
Benzinga
Lucy Scientific's Fiscal Year: Operating Expenses Rise As Accumulated Deficit Hits Over $44M
October 17, 2023
Tickers
LSDI
Tags
News
Benzinga
Psychedelics
From
Benzinga
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
October 16, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
CYBN
Small Cap
Penny Stocks
From
Benzinga
U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy
October 15, 2023
Tickers
AWKNF
Tags
Prof/ David Nutt
ScholarGPS
Psychedelic/Assisted Therapies
From
Benzinga
Dem Presidential Candidate Calls For Universal Healthcare, Including Psychedelics Therapy
October 13, 2023
Tags
Cannabis
mental health
Presidential race
From
Benzinga
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates
October 13, 2023
Tickers
CYBN
DMTTF
Tags
Penny Stocks
Market News
Cannabis
From
Benzinga
Pioneering Hope: Inside The Veteran's Organization Advancing Psychedelics Reform Policy
October 12, 2023
Tags
Markets
Brett Waters
Ret/ Marine LtGen Martin Steele
From
Benzinga
EXCLUSIVE: Understanding Real Estate For Psychedelic Treatments Boosted By Geospatial Mapping
October 07, 2023
Tickers
AAPL
IBM
Tags
Markets
Real Estate
Psychedelics
From
Benzinga
EXCLUSIVE: The Need To Enhance Psychedelic Therapy Infrastructure, Data-Driven Solutions
October 06, 2023
Tags
Market News
Healing Realty Trust
Cannabis
From
Benzinga
Maine's Portland Leads Drug Policy Reform, Decriminalizing Psychedelic Plants And Fungi
October 04, 2023
Tags
Benzinga
Management
Psychedelic/Assisted Therapies
From
Benzinga
Decoding Insurance Reimbursement For Psychedelic-Assisted Therapy With BrainFutures Guide
October 04, 2023
Tags
News
Benzinga
Psychedelic/Assisted Therapies
From
Benzinga
Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation
October 03, 2023
Tickers
ATAI
Tags
Psychedelic/Assisted Therapies
Management
Benzinga
From
Benzinga
Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment
October 03, 2023
Tickers
CYBN
Tags
Psychedelics
Markets
News
From
Benzinga
Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares
October 03, 2023
Tickers
BNOX
CYBN
MRK
Tags
Steve Cohen
Financing
Psychedelic/Assisted Therapies
From
Benzinga
Insider's Look At Psychedelics Industry On Risk Management, Gray Market & Cannabis Industry
October 03, 2023
Tags
Markets
Psychedelics
Exclusives
From
Benzinga
GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
October 02, 2023
Tickers
GHRS
Tags
Investigational New Drug Application
Market News
Cannabis
From
Benzinga
Gov Newsom Green Lights Medical Psychedelics If Rescheduled And New Marijuana Testing Rules
October 02, 2023
Tags
News
Psychedelic/Assisted Therapies
Benzinga
From
Benzinga
Psychedelic Therapy Providers: Risk Management Perspective From A Cannabis Insurance Specialist
October 02, 2023
Tags
Market News
Legal
Cannabis
From
Benzinga
Argentina's Nacho Bottinelli On Psychedelics In Latin America: 'Brazil Opened A Giant Portal To Me'
October 02, 2023
Tags
Markets
Brazil Psychedelics
Latin America Psychedelics
From
Benzinga
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
October 02, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
SILO
PHRRF
HUGE
From
Benzinga
Psychedelics Reform Update: Massachusetts, Pennsylvania, Maine, California, Michigan, Minnesota, Indiana
September 30, 2023
Tags
Cannabis
Legal
Politics
From
Benzinga
PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance
September 27, 2023
Tickers
PHRRF
Tags
PHRRF
General
FDA
From
Benzinga
Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression
September 26, 2023
Tickers
CYBN
Tags
Psychedelic/Assisted Therapies
Management
Global
From
Benzinga
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
September 26, 2023
Tickers
CYBN
DMTTF
Tags
CYBN
Psychedelic/Assisted Therapies
Management
From
Benzinga
Defense Dept. Grants $1M To Yale & Transcend Therapeutics To Study PTSD Therapy
September 26, 2023
Tags
Department of Defense
Benzinga
News
From
Benzinga
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
September 26, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
NKE
PSIL
Markets
From
Benzinga
Microdosing Unveiled: Expert's Take On The Practice's Ups & Downs
September 24, 2023
Tickers
META
Tags
News
Interview
Benzinga
From
Benzinga
Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression
September 21, 2023
Tickers
CYBN
DMTTF
Tags
Penny Stocks
Markets
Psilocybin program
From
Benzinga
Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives, Details Here
September 21, 2023
Tickers
ENVB
Tags
Markets
Penny Stocks
Psilocybin program
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.